A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: The Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial

Trials

Volumn 11, Issue , 2010, Pages

  Rietdijk, Judith ^a   Dragt, Sara ^b   Klaassen, Rianne ^b,c   Ising, Helga ^a,g   Nieman, Dorien ^b   Wunderink, Lex ^d   Delespaul, Philippe ^e,f   Cuijpers, Pim ^a   Linszen, Don ^b   van der Gaag, Mark ^a,g  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GGZ Rivierduinen   (Netherlands)

^d Department of Education and Research ^*  (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f Department of Integral health care Maastricht/Parkstad   (Netherlands)

^g PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPREHENSIVE ASSESSMENT OF AT RISK MENTAL STATE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; EARLY INTERVENTION; HELP SEEKING BEHAVIOR; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENTAL HEALTH; MENTAL HEALTH SERVICE; MENTAL TEST; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PSYCHOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; CHI SQUARE DISTRIBUTION; KAPLAN MEIER METHOD; METHODOLOGY; MORTALITY; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MENTAL HEALTH SERVICES; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951625609     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-30     Document Type: Article

References (51)

1. Birchwood M, Spencer E. Early intervention in psychotic relapse. Clinical Psychological Review 2001, 22:1211-1226.
2. Falloon IRH, Kydd RR, Coverdale JH, Laldlaw TM. Early detection and intervention for initial episodes of schizophrenia. Schizophrenia Bulletin 1996, 22:271-288.
3. McGorry PD, Edwards J. The feasibility and effectiveness of early intervention in psychotic disorders: the Australian experience. International Clinical Psychopharmalogy 1998, 13:S47-S52.
4. Larsen TK, Friis S, Haahr U, et al. Early detection ans intervention in First-episode schizophrenia: a critical review. Acta Psychiatrica Scandinavica 2001, 103:323-334. 10.1034/j.1600-0447.2001.00131.x, 11380302.
5. Linszen Don H, Dingemans P, Does JW, Nugter A, Scholte P, Lenior R, Goldstein MJ. Treatment, expressed emotion ans relapse in recent onset schizophrenic disorders. Psychological Medicine 1996, 26:333-342. 10.1017/S0033291700034723, 8685289.
6. Yung AR, McGorry PD. The Prodromal Phase of First-Episode Psychosis: Past and Current Conceptualizations. Schizophrenia Bulletin 1996, 22:353-370.
7. McGorry PD, MacFarlane C, Patton GC, et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatrica Scandinavica 1995, 95:241-249.
8. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey EJ, Stanford C, et al. Mapping the onset of psychosis--the Comprehensive Assessment of At Risk Mental States (CAARMS). Australian and New Zealand Journal of Psychiatry 2005, 39:964-971.
9. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research 2003, 60:21-32. 10.1016/S0920-9964(02)00167-6, 12505135.
10. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, et al. Declining Transition Rate in Ultra High Risk (Prodromal) Services: Dilution or Reduction of Risk?. Schizophrenia Bulletin 2007, 33:673-681. 10.1093/schbul/sbm015, 2526154, 17404389.
11. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey EJ, Phillips LJ, Bechdolf A, Buckby JA, McGorry PD. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophrenia Research 2008, 105:10-17. 10.1016/j.schres.2008.07.012, 18765167.
12. McGlashan TH, Zipursky RB, Perkins D, et al. Randomized double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry 2006, 163:790-799. 10.1176/appi.ajp.163.5.790, 16648318.
13. McGorry PD. "A stitch in time"... the scope for preventive strategies in early psychosis. European Archives of Clinical Neuroscience 1998, 248:22-31.
14. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Bitish Journal of Psychiatry 2004, 185:291-297.
15. Nordentoft M, Thorup A, Petersen L, Øhlenschlæger J, Melau M, Østergaard Christensen T, Krarub G, Jørgensen P, Jeppesen P. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophrenia Research 2006, 83:29-40. 10.1016/j.schres.2006.01.002, 16504481.
16. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry 1992, 149:1183-1188.
17. Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, Francey SM, Yung AR. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophrenia Research 2007, 96:25-33. 10.1016/j.schres.2007.05.018, 17611080.
18. De Koning M, Bloemen OJN, Van Amelsvoort T, Becker HE, Nieman DH, Gaag M, Linszen DH. Early intervention in patients at ultra high risk of developing psychosis: benefits and risks. Acta Psychiatrica Scandinavica 2009, 3:1-17.
19. McGorry PD, Nelson B, Amminger P, Bechdolf A, Francey SM, Berger G, Riecher-Rossler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, et al. Intervention in Individuals at Ultra High Risk for Psychosis: a Review and Future Directions. Journal of Clinical Psychiatry 2009, e1-e7.
20. French P, Morrison AP, Walford L, et al. Cognitive therapy for preventing transition to psychosis in high risk individuals: a case series. Behaviour Research and Therapy 2003, 31:53-68.
21. French P, Morrison AP. Early Detection and CognitiveTherapy for People at High Risk of Developing Psychosis: ATreatment Approach 2004, London: John Wiley & Sons.
22. Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD. The Prodromal Questionaire (PQ): Preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophrenia Research 2005, 79:117-125. 10.1016/j.schres.2005.03.007, 16276559.
23. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry 1992, 149:1148-1156.
24. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort. Schizophrenia Bulletin 1998, 24:75-85.
25. James IA, Blackburn IM, Reichelt FK. Manual of the Revised Cognitive Therapy Scale (CTSR) 2001, Newcastle: Northumberland, Tyne & Wear NHS Trust.
26. Loewy RL, Johnson JK, Cannon TD. Self-report of attenuated psychotic experiences in a college population. Schizophrenia Research 2007, 93:144-151. 10.1016/j.schres.2007.02.010, 2063995, 17459662.
27. Andrews G, Peters L. The psychometric properties of the Composite International Diagnostic Interview. Social Psychiatry Psychiatric Epidemiology 1998, 33:80-88.
28. Wittchen H-U. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. Journal of Psychiatric Research 1994, 28:57-84. 10.1016/0022-3956(94)90036-1, 8064641.
29. Luteijn F, Ploeg FAE. Handleiding Groninger Intelligentietest (GIT) [Manual Groningen Intelligence Test] 1983, Lisse, The Netherlands: Swets & Zeitlinger.
30. Allen HA, Liddle PF, Frith CD. Negative features, retrieval processes and verbal fluency is schizophrenia. Bitish Journal of Psychiatry 1993, 163:769-775.
31. Becker HE, Nieman DH, Dingemans PM, Fliert R, De Haan L, Linszen DH. Verbal Fluency as a possible predictor for psychosis. European Psychiatry 2009,
32. Does JW. The Dutch version of the Beck Depression Inventory- (BDI-II-NL) (In Dutch) 2002, Lisse: Swets Test Publishers, second.
33. Addington D, Addington J, Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophrenia Research 1994, 11:239-244. 10.1016/0920-9964(94)90017-5, 8193062.
34. Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behaviour Research and Therapy 1998, 36:455-470. 10.1016/S0005-7967(97)10031-6, 9670605.
35. Veling W, Selten JP, Mackenbach JP, Hoek HW. Symptoms at first contact for psychotic disorder: Comparison between native Dutch and ethnic minorities. Schizophrenia Research 2007, 95:30-38. 10.1016/j.schres.2007.06.024, 17669627.
36. Veling W, Selten JP, Susser E, Laan W, Mackenbach JP, Hoek HW. Discrimination and the incidence of psychotic disorders among ethnic minorities in The Netherlands. International Journal of Epidemiology 2007, 36:761-768. 10.1093/ije/dym085, 17517810.
37. Birchwood M, Mason R, MacMillan JF, et al. Depression, demoralisation and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychological Medicine 1993, 23:387-395. 10.1017/S0033291700028488, 8332655.
38. Brooks R, . EuroQol-Group EuroQol: the current state of play. Health Policy 1996, 37:53-72. 10.1016/0168-8510(96)00822-6, 10158943, EuroQol-Group.
39. Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry 1999, 45:7-12. 10.1177/002076409904500102, 10443245.
40. Kay SR, Fiszbein A, Opler A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
41. Haddock G, McCannon J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine 1999, 29:879-889. 10.1017/S0033291799008661, 10473315.
42. Giel R, Nienhuis FJ. SCAN-2.1: Schedules for Clinical Assessment in Neuropsychiatry (in Dutch) Vragenschema's voor klinische beoordeling in neuropsychiatrie. 1996, Geneva/Groningen, World Health Organisation.
43. Chapman J. The Early Symptoms of Schizophrenia. Bitish Journal of Psychiatry 1966, 112:225-251.
44. Gottesman II, Shields J. Schizophrenia: The epigenetic puzzle 1982, Cambridge: Cambrigde Press.
45. Spauwen J, Krabbendam L, Lieb R, Wittchen H-U, van Os J. Early maternal stress and health behaviours and offspring expression of psychosis in adolescence. Acta Psychiatrica Scandinavica 2004, 110:356-364. 10.1111/j.1600-0447.2004.00429.x, 15458559.
46. van Os J, Bak J, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 2002, 156:319-327. 10.1093/aje/kwf043, 12181101.
47. Bernaards CA, Sijtsma K. Influence of Imputation and EM Methods on Factor Analysis when Item Non-response in Questionnaire Data is Nonignorable. Multivariate Behavioral Research 2000, 35:321-364.
48. Little RJA, Rubin DB. The Analysis of Social Science Data with Missing Values. Socialogical Methods and Research 1989, 18:292-326.
49. Nieman DH, Rieke WH, Becker HE, Dingemans PM, Van Amelsvoort TA, De Haan L, Gaag M, Denys DAJP, Linszen DH. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis. International Clinical Psychopharmalogy 2009, 24:223-228.
50. Os JV, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophrenia Research 2000, 45:11-20. 10.1016/S0920-9964(99)00224-8, 10978868.
51. Spauwen J, Krabbendam L, Lieb R, Wittchen H-U, van Os J. Sex differences in psychosis: normal or pathological?. Schizophrenia Bulletin 2003, 62:45-49.